ライフサイエンスコーパス: we describe

1 We describe 10 straightforward writing tips-and a web tool, P

2 We describe 2 cases of renal lymphangiectasia in transplanted

3 We describe 47 patients referred to our hospital between 21 F

4 We describe a Bayesian hierarchical model, called Bayesian In

5 We describe a lethal combined nervous and reproductive system

6 We describe a specific example of a gAP in humans linked to i

7 We describe a strategy performed in Brazil to enable and acce

8 We describe invasive MRSA trends by strain type.

9 We describe our design, synthesis, and chemical study of a se

10 We describe the emergence of a protein domain that confers th

11 We describe the partial cranium and skeleton of a new diproto

12 We described a detailed SAR in TLR2 agonistic scaffolds and a

13 We described the overall uptake of telemonitoring and uptake

14 In addition, we describe research pipelines that broaden evidence-based ap

15 ate the synthesis of paromomycin and/or neomycin analogues, we describe a cleavage of ring I from paromomycin that procee

16 of the BBSome by itself and in complex with ARL6(GTP), and we describe the changes in BBSome conformation induced by ARL

17 Here we describe a method for isolating human gut-associated lymph

18 Here we describe a platform for efficient Cas12a gene editing in D

19 Here we describe a platform for the detection of IgG anti-drug ant

20 Here we describe a robust genetic program that intrinsically atten

21 Here we describe an ex vivo cultured human skin explant model in w

22 Here we describe an ultrasensitive form of polymerization-based re

23 Here we describe the production of a range of mini-spidroins with

24 Here we describe the use of discarded wound dressings as a novel,

25 Here, we describe a function for NEK10 in the regulation of p53 tra

26 Here, we describe a mechanism by which the innate immune system all

27 Here, we describe a new fossil specimen from Drimolen Main Quarry,

28 Here, we describe a rare case of highly efficient near-cognate init

29 Here, we describe an optimization strategy for reducing scrambling

30 Here, we describe the development and use of an assay to monitor th

31 Here, we describe the extent of resistance of E. dermatitidis to ac

32 Here, we describe the two-phase process by which antigen drives the

33 Here, we describe the UBPs developed by three research teams and th

34 lariopsis cylindrus and Pseudo-nitzschia multistriata Here, we describe how functional genomics and reverse genetics have

35 Here, we described a new, comprehensive system of in silico methods

36 Herein, we describe bacterial metabolites with known or suspected neu

37 Herein, we describe how a biomimetic synthesis of bruceol, a pentacyc

38 Herein, we describe light-responsive tethers, containing an azobenzen

39 Herein, we describe the design and performance of an integrated micro

40 Herein, we describe the discovery and optimization of a class of pote

41 Herein, we describe the mechanisms and consequences of TLR-mediated s

42 In this Perspective, we describe efforts to decipher heterogeneity in T2D and deta

43 Previously, we described a strategy to rapidly identify and generate llam

44 In this report, we describe the utility of one of these enzymes, Nepenthesin

45 In this Review we describe the epidemiology, clinical features, course, and

46 In this retrospective cohort study, we describe the clinical presentation and workup of parathyro

47 In this study, we describe a new approach for preparing islets that enhances

48 In this study, we describe a novel high throughput, micro-macro approach for

49 In this study, we describe an active poultry surveillance system established

50 sence of heterogeneous spatial sequences of metal ions that we describe, depending on the metal and synthesis temperature